CESSARA

Serial Number 78972483
606

Registration Progress

Application Filed
Sep 12, 2006
Under Examination
Jan 8, 2008
Approved for Publication
Sep 26, 2007
Published for Opposition
Oct 16, 2007
Registered

Basic Information

Serial Number
78972483
Filing Date
September 12, 2006
Published for Opposition
October 16, 2007
Abandonment Date
February 7, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 7, 2011
Classes
005

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
130 Waverly Street
Cambridge, MA 02139

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Cambridge, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
STEVEN A. ABREU

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Feb 7, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Feb 7, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 13, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2010 EX5G S SOU EXTENSION 5 GRANTED
Jul 8, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 8, 2010 EXT5 S SOU EXTENSION 5 FILED
Jan 11, 2010 EX4G S SOU EXTENSION 4 GRANTED
Jan 7, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 7, 2010 EXT4 S SOU EXTENSION 4 FILED
Nov 24, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 28, 2009 EX3G S SOU EXTENSION 3 GRANTED
Jul 6, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 6, 2009 EXT3 S SOU EXTENSION 3 FILED
Dec 22, 2008 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 22, 2008 EXT2 S SOU EXTENSION 2 FILED
Dec 22, 2008 EX2G S SOU EXTENSION 2 GRANTED
Jul 7, 2008 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 7, 2008 EXT1 S SOU EXTENSION 1 FILED
Jul 7, 2008 EX1G S SOU EXTENSION 1 GRANTED
Jan 8, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 16, 2007 PUBO A PUBLISHED FOR OPPOSITION
Sep 26, 2007 NPUB O NOTICE OF PUBLICATION
Sep 11, 2007 ALIE A ASSIGNED TO LIE
Sep 11, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 2, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2007 DOCK D ASSIGNED TO EXAMINER
Feb 2, 2007 CPRA R PRIORITY ACTION WRITTEN
Feb 2, 2007 GPRA F PRIORITY ACTION E-MAILED
Sep 18, 2006 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of viral diseases, cancer, cystic fibrosis, and inflammation
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005